All these factors were secreted in a similar RT-induced time- and dose-dependent manner from several NSCLC cell lines (and other tumor entities), indicative of a common upstream mechanism without changes at the transcriptional level, pointing towards ADAM17. This evidence concerns the gene ADAM17 and non-small cell lung carcinoma.